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Preneoplasic  and  neoplastic  changes  of  the  gallbladder  of  patients  with  a familial  adenomatous  polyposis
(FAP)  are  rare,  and  very  little  is known  about  their incidence  in  patients  with  an  attenuated  FAP.  We  herein
report  on  a  unique  case  of a woman  with  an  attenuated  FAP  who  shows  eight  distinct,  partially  preneoplas-
tic  differentiation  patterns  within  the  gallbladder  mucosa,  which  are:  (1)  regular  gallbladder  epithelium,
(2)  low  grade  biliary  intraepithelial  neoplasia,  (3)  papillary  adenoma,  (4)  Paneth  cell  metaplasia,  (5)  goblet
cell  metaplasia,  (6)  pancreatic  metaplasia,  (7)  pseudopyloric  metaplasia,  and  (8)  neuroendocrine  differ-
entiation.  Moreover,  this  is the ﬁrst case of  a KRAS  mutation  in  a gallbladder  adenoma  of  a patient  with
an APC  germline  mutation,  which  is highly  suggestive  of  an  early  event  of malignant  transformation.  As  a
consequence  of  our  ﬁndings,  clinicians  should  draw  special  attention  to the  gallbladder  of FAP  patients,
and  a simultaneous  protective  cholecystectomy  of  FAP  patients,  which  undergo  colectomy  and  show  con-
spicuous  changes  of the  gallbladder  mucosa,  should  be  performed  in  these  patients  in  order  to  eliminate
the  risk  of a synchronous  or metachronous  gallbladder  neoplasia.
© 2015  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CCntroduction
Familial adenomatous polyposis (FAP) is an autosomal domi-
ant inherited polyposis syndrome that is caused by a mutation of
he adenomatous polyposis coli (APC) gene. It comes along not only
ith a large number of colorectal adenomas and a highly increased
isk for the development of colorectal cancer, but also with an asso-
iation with extra-colorectal tumors, as it is referred to as Gardner’s
yndrome. Extracolonic benign and malignant tumors and their
reliminary stages occur mainly in the stomach, skin and soft tissue,
ut, although rare, also APC mutation associated neoplasms of the
allbladder are described [1]. Until now, only 11 cases of Gardner’s
yndrome associated gallbladder adenomas, respectively, six cases
f gallbladder adenocarcinomas have been reported, and nothing
s known about other precancerous lesions or simultaneous gene
utations [2].
Patients with attenuated FAP do not fulﬁll the complete criteria
or FAP, as they have less than 100 colorectal polyps. Extracolonic
anifestations are rare and mainly restricted to gastric polyps, and
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nothing is described about epithelial alterations of the gallbladder
within these patients.
Here, we  report for the ﬁrst time on a case of a woman  with
an attenuated FAP who shows eight distinct differentiation pat-
terns of the gallbladder mucosa, which include a wide range
of precancerous lesions. We  found no other name in the litera-
ture for this complex metaplastic and dysplastic lesion that we
named “complex APC germline mutation associated metaplasia
and intraepithelial neoplasia (CAM-IEN) of the gallbladder” and
that is a novel carcinogenesis model of the gallbladder, with the
possibility to gain new insights into tumor biology.
Clinical history
A 53-year-old woman with a previously known atten-
uated FAP and a conﬁrmed APC germline mutation
(c.4788delC:p.Gin1596Argfs*54) underwent subtotal colec-
tomy with simultaneous cholecystectomy for cholecystolithiasis.
The examination of the colectomy specimen revealed multiple
residuals of afore endoscopically removed colorectal adenomas
with low grade intraepithelial neoplasia according to the WHO-
classiﬁcation. The gallbladder measured 89 × 28 × 25 mm  and
contained multiple gallstones with a size of up to 17 mm.  The
gallbladder wall measured 4 mm in maximum thickness. The
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Fig. 1. The eight distinct differentiation patterns of the gallbladder mucosa.
The regular gallbladder epithelium merges abruptly into a low grade biliary intraepithelial neoplasia (A–D). The regular gallbladder epithelium is immunohistochemically
positive for cytokeratin 7 (B) and negative for CDX2 (C) and cytokeratin 20 (D), whereas the biliary intraepithelial neoplasia is vice versa negative for cytokeratin 7 (B) and
positive  for CDX2 (C) and for cytokeratin 20 (D). The other differentiation patterns are: Papillary adenoma with an overexpression of LGR5 (E, F); mucin 2-positive Paneth
cell  metaplasia (G, H); periodic acid-Schiff reaction positive goblet cell metaplasia (I, J); trypsin-positive pancreatic metaplasia (K, L); pseudopyloric metaplasia (M)  that is
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C);  cytokeratin 20 (D); LGR5 (F); mucin 2 (H); periodic acid-Schiff reaction (J); tryp
-P)  and ×300 (G, H, K and L).
pecimen showed no macroscopic abnormalities, apart from a
artial plane polypoid mucosa of 8 mm in diameter.
aterial and methods
mmunohistochemical analysis
Serial sections of 2.5 m thickness were obtained from
ormalin-ﬁxed and parafﬁn-embedded tissue specimens. Immuno-
istochemical stainings were carried out with a Bondmax
Leica Biosystems, Wetzlar, Germany) automated slide staining
ystem, using the Polymer Reﬁne Detection Kit (Menarini Diag-
able 1
mmunohistochemical proﬁle of the eight differentiation patterns of the gallbladder muc
Antigen Differentiation
Regular
gallbladder
epithelium
Low grade biliary
intraepithelial
neoplasia
Papillary
adenoma
Cytokeratin 7 + − + 
Cytokeratin 20 − + − 
CDX2  − + − 
Mucin  1 − − − 
Mucin  2 − Single cells + − 
Mucin  5 − − − 
CD10  + − 
Trypsin − − − 
-catenin (nuclear) − − − 
p53  Single cells (+) Single cells (+) − 
Chromogranin A − − − 
Synaptophysin − − − 
LGR5  − − + 
Trefoil  factor 2 − − − 
+” denotes positivity, “(+)” denotes weak positivity, “−” denotes negativity.tophysin (P). Hematoxylin and eosin (A, E, G, I, K, M and O); cytokeratin 7 (B); CDX2
; trefoil factor 2 (N); synaptophysin (P). Original magniﬁcations ×400 (A–F, I, J and
nostics, Berlin, Germany). For immunohistochemistry, we used
monoclonal mouse antibodies, directed against -Catenin (clone
CAT5H10; Zytomed Systems, Berlin, Germany; dilution 1:300),
CDX2 (clone AMT28; Novocastra Laboratories Ltd, Newcastle,
United Kingdom; 1:20), chromogranin A (clone LK2H10; Biologo,
Kronshagen, Germany; 1:100), CD10 (clone 56C6; Novocastra;
1:10), cytokeratin 7 (CK7; clone RN7; Novocastra; 1:100), cyto-
keratin 20 (CK20; clone Ks20.8; NeoMarkers, Fremont, United
States of America; 1:50), mucin 1 (Muc1; clone Ma695; Novo-
castra; 1:100), mucin 2 (Muc2; clone Ccp58; Novocastra; 1:100),
mucin 5 (Muc5; clone 45M1; NeoMarkers; 1:100), p53 (clone
DO-7; Novocastra; 1:100), trefoil factor 2 (TFF2; clone GE16C;
osa.
Paneth cell
metaplasia
Goblet cell
metaplasia
Pancreatic
metaplasia
Pseudopyloric
metaplasia
Neuroendocrine
differentiation
+ + + − −
− + − − −
− − − − −
− − − − −
+ + − − −
− − (+) − −
− − − − −
− − + − −
− − − − −
− − − − −
− − − − +
(+) − − − +
− − − − −
− − − + −
56 C. Böger et al. / Pathology – Research 
Fig. 2. Overview of the gallbladder.
The gallbladder contains a papillary adenoma (A1, B), a low grade biliary intraep-
ithelial neoplasia (A2, C), and regular gallbladder epithelium (A3, D). These
three morphologically peculiar areas within the gallbladder mucosa were manu-
ally microdissected separately, and mutational analysis of codons 12/13, 61, 117 andand Practice 212 (2016) 54–58
Leica Biosystems, Newcastle, United Kingdom; 1:10), respectively,
monoclonal rabbit antibodies, directed against synaptophysin
(clone SP11; NeoMarkers; 1:50), and polyclonal rabbit antibod-
ies, directed against trypsin (BioDesign, Memphis, United States of
America; 1:1000) and LGR5 (LGR5-11b; 1:1000) [3]. Pretreatment
was done with ER2 (anti-CDX2, anti--Catenin) or ER1 (anti-CD10,
anti-CK7, anti-CK20, anti-LGR5, anti-Muc1, anti-Muc2, anti-p53,
anti-synaptophysin, anti-TFF2) for 20 min. No pretreatment was
done for anti-chromogranin A, anti-Muc5, and anti-trypsin. All anti-
bodies were diluted in antibody diluent (Zytomed Systems, Berlin,
Germany).
Microdissection and DNA extraction
Three morphologically peculiar areas within the gallbladder
(see below in Molecular ﬁndings) were manually microdissected
separately. Genomic DNA was extracted from formalin-ﬁxed and
parafﬁn-embedded tissue using the QIAamp DNA mini kit (Qiagen,
Hilden, Germany) following the manufacturer’s instructions.
Mutational analysis
Mutational analysis of codons 12/13, 61, 117 and 146 of the
KRAS and NRAS genes, codon 600 of the BRAF gene, and muta-
tional hotspots in exons 8 and 9 of the GNAS gene were performed
by pyrosequencing on a PyroMark Q24 instrument (Qiagen). Frag-
ments of the different genes were ampliﬁed by polymerase chain
reaction.
Results
Histopathologic ﬁndings
After complete embedding of the cholecystectomy specimen,
we found eight differentiation patterns within the mucosa, which
were: (1) regular gallbladder epithelium, (2) low grade biliary
intraepithelial neoplasia (BilIN-1), (3) papillary adenoma with
intermediate grade dysplasia, (4) Paneth cell metaplasia, (5)
goblet cell metaplasia, (6) pancreatic metaplasia, (7) pseudopy-
loric metaplasia, and (8) neuroendocrine differentiation. The light
microscopic ﬁndings of the various phenotypes were conﬁrmed
by immunohistochemistry (Table 1, Fig. 1). No relevant inﬂam-
matory inﬁltrate, respectively, chronic inﬂammatory changes were
observed.
Additionally, we  explored three other, previously examined
gallbladder specimens of FAP patients from the archive of the Insti-
tute of Pathology, University Hospital Kiel. These cases showed
neither preneoplastic nor neoplastic changes of the mucosa.
Molecular ﬁndings
On the basis of the morphologic and immunohistochemical ﬁnd-
ings, we  performed mutational analysis of codons 12/13, 61, 117
and 146 of the KRAS and NRAS genes, codon 600 of the BRAF gene,
and mutational hotspots in exons 8 and 9 of the GNAS gene of three
distinct phenotypic areas (Fig. 2). Area 1 contained the papillary
adenoma with intermediate grade dysplasia and showed a gene
mutation of codon 12/13 of the KRAS gene (c.34G > T; p.G12C) which
results in an amino acid substitution at position 12 in KRAS-protein,
from a glycine to a cysteine. Area 2 (BilIN1) and area 3 (regular
146 of the KRAS and NRAS genes, codon 600 of the BRAF gene, and mutational
hotspots in exons 8 and 9 of the GNAS gene was performed separately for each
phenotype. Hematoxylin and eosin, original magniﬁcations ×5.3 (A); ×50 (B); ×100
(C); ×30 (D).
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allbladder epithelium) showed no mutation within the examined
odons and exons of KRAS, NRAS, BRAF or GNAS.
iscussion
We  herein report the ﬁrst case of a complex APC germline
utation-associated metaplasia and intraepithelial neoplasia of
he gallbladder in a patient with an attenuated FAP. Dysplastic
hanges, adenomas and carcinomas of the gallbladder in patients
ith an APC germline mutation are – although extremely rare –
lready known, but to date, nothing has been described about
omplex synchronous metaplastic and dysplastic changes of the
allbladder mucosa of these patients, and nothing is known about
hese changes in patients with attenuated FAP. In general, FAP
atients are at increased risk of developing other types of cancer
nd mucosal alterations, such as fundic gland polyps and cancer of
he stomach, as well as cancer of the small intestine [4]. However,
 complex metaplasia as described here has not been found at any
ther organ site, e.g. stomach, small and large intestine, leading to
he conjecture that the gallbladder provides a unique environment
or metaplasia and dysplasia. At least 40% of the patients with FAP,
ho underwent cholecystectomy, are known to have epithelial
ysplasia of the gallbladder [5], which might be related to a higher
iliary bile acid concentration: The bile of patients with FAP is
escribed to have a greater proportion of deoxycholic acid than the
ile of patients without FAP [6]. Bile acids inﬂuence, e.g. the cellular
roliferation and differentiation of colorectal epithelial cells, and
ay  also be relevant for the development of biliary dysplasia [7].
In routine cholecystectomy specimens, metaplastic changes of
he mucosa are frequent but never of this complex phenotype. In
eneral, they seem to be associated with patient gender and age and
re considered to be precursor lesions of dysplastic changes of the
allbladder mucosa [8]. In the gallbladder, adenoma and dysplasia
re regarded as distinct lesions that are both associated with a
ighly increased risk for carcinoma development [9]. In this regard,
ncidental adenomas as precursor lesions for gallbladder adenocar-
inoma are rare, whereas the metaplasia → dysplasia → carcinoma
n situ → invasive gallbladder carcinoma sequence is much more
revalent and well-established in the concept of gallbladder cancer
10].
Several gene mutations, including mutations within the WNT-
ignaling pathway, KRAS, BRAF and TP53, are known to play a
ole in gallbladder carcinogenesis [11]. Within the WNT-signaling
athway, APC is closely connected to -catenin. In non-neoplastic
allbladder epithelium, the -catenin expression is solely mem-
ranous, whereas a nuclear expression comes along with -catenin
utations, as they are known to appear in neoplastic changes. All
ight epithelial phenotypes found in the gallbladder mucosa of
ur patient showed a moderate to strong membranous -catenin
xpression, whereas they lacked a nuclear -catenin expression.
his observation conﬁrms previous ﬁndings, which state that
yperplastic and dysplastic gallbladder epithelium shows a mem-
ranous -catenin expression, whereas a nuclear or cytoplasmic
ccumulation is mainly reserved to gallbladder carcinomas [2,12].
hus, the presence of a ˇ-catenin mutation may  not be present
n our patient. KRAS gene mutations are known to be involved in
he development of gallbladder adenoma, dysplasia and carcinoma
13]. In contrast to the minor role that adenomas play in the car-
inogenesis of sporadic gallbladder carcinoma, the combination of
 gallbladder adenoma with a KRAS mutation in a patient with an
PC germline mutation may  have further interesting implications:1) In colorectal adenoma, an APC loss results in the initiation of
an adenoma, whereas the progression to a carcinoma needs a
second hit, as it is fulﬁlled, e.g. by a KRAS mutation [14]. As thisand Practice 212 (2016) 54–58 57
is the ﬁrst case of a KRAS mutation in a gallbladder adenoma of
a patient with an APC germline mutation, this case may provide
evidence that a similar sequence of events may  also initiate
gallbladder cancer.
(2) The combination of a KRAS-mutation of a gallbladder adenoma
against the background of an APC germline mutation is highly
suggestive of an early event of malignant transformation. This
conclusion is moreover supported by the proven LGR5 overex-
pression within the adenoma, which is known to be associated
with cancer progression in other gastrointestinal tumor entities
[3,15].
Conclusion
We herein report on a unique case of complex metaplastic and
dysplastic changes of the gallbladder and, moreover, the ﬁrst case
of a KRAS mutation in a gallbladder adenoma of a patient with an
APC-germline mutation. The combination of our ﬁndings is highly
suggestive of an early event of malignant transformation. As a con-
sequence of our ﬁndings, clinicians should draw special attention
to the gallbladder of FAP patients, and a simultaneous protective
cholecystectomy of FAP patients, which undergo colectomy and
show conspicuous changes of the gallbladder mucosa, should be
performed in these patients in order to eliminate the risk of a syn-
chronous or metachronous gallbladder neoplasia.
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